list : Pediatrics
-
Drug eases opioid withdrawal in babies
In a new clinical trial, Stanford Medicine researchers found that a commonly used anti-nausea drug could reduce the severity of opioid withdrawal in newborns.
-
Improving end-of-life care for kids
Research into medical decisions for children with terminal illnesses can be improved by sensitively tapping the expertise of families who have lost a child, according to Stanford Medicine experts.
-
$10 million for autism, sleep research
About 80% of children with autism have trouble sleeping, but whether better sleep could lessen other autism symptoms is unknown. A new grant will help Stanford Medicine scientists find out.
-
Parents’ PTSD after child’s medical trauma
Nearly half of parents with a child who received an implantable device to correct abnormal heart rhythms met criteria for post-traumatic stress disorder, a Stanford Medicine-led study found.
-
Blood sugar control helps teens’ brains
Diabetes treatment technology improved teenagers’ blood sugar levels and benefited their brain structure and function, according to a study led by Stanford Medicine researchers.
-
Pediatric emergency department recognized
Santa Clara County recognized Stanford’s pediatric emergency department for its ability to handle a broad spectrum of medical emergencies in young patients.
-
COVID vaccine approved for young kids
Children as young as 6 months can now receive the Pfizer BioNTech and Moderna mRNA vaccines.
-
Immunosuppression-free kidney transplant
Using a method they developed for stem cell transplants, a Stanford team has enabled children with immune disorders to receive a new immune system and a matching kidney from a parent.
-
$13 million for cancer research
The funding, from Cancer Grand Challenges, will help the researchers address difficult problems in cancer prevention, treatment-resistant cancers and therapies for pediatric solid tumors.
-
Bacteria that digest breast milk in decline
Stanford Medicine researchers and colleagues found that as nations industrialize, a species of bacteria critical in the early development of infant gut microbiomes fades away.